ESC Video reports from ACC 2010: Ferrari, Verheugt, Valgimigli

The ESC Communications Team attended ACC.10 in Atlanta, USA from 13 to 17 March, providing live coverage of the conference.

Date: 17 Mar 2010

These reports focus primarily on the late breaking clinical trials by asking fellow European cardiologists to comment on what they've seen and heard, on the spot. This page includes reports from ESC President R. Ferrari, F. Verheugt and M. Valgimigli.

A few words from European Society of Cardiology (ESC) President Professor Roberto Ferrari, FESC, while at ACC.10.

Prof. F. Verheugt, Amsterdam, NL, comments on ACC.10 late breaking clinical trials. Effect of Genotyping Warfarin Patients on Outcomes: Results from The National Community-based Medco-Mayo Warfarin Effectiveness Study (MM-WES)

Prof. M. Valgimigli, FESC, Ferrara, Italy, comments on three ACC.10 Intervention late breaking clinical trials: JETSTENT, PASSION and DEDICATION

Prof. F. Verheugt, Amsterdam, NL, comments on the results from the PLATO trial presented by Claes Held, Uppsala, Sweden